
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The heightened importance of the microbiome in cancer immunotherapy
C Villemin, Anne Six, Bridget A. Neville, et al.
Trends in Immunology (2022) Vol. 44, Iss. 1, pp. 44-59
Open Access | Times Cited: 49
C Villemin, Anne Six, Bridget A. Neville, et al.
Trends in Immunology (2022) Vol. 44, Iss. 1, pp. 44-59
Open Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 146
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 146
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 55
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 55
Vitamin D regulates microbiome-dependent cancer immunity
Evangelos Giampazolias, Mariana Pereira da Costa, Khiem C. Lam, et al.
Science (2024) Vol. 384, Iss. 6694, pp. 428-437
Open Access | Times Cited: 42
Evangelos Giampazolias, Mariana Pereira da Costa, Khiem C. Lam, et al.
Science (2024) Vol. 384, Iss. 6694, pp. 428-437
Open Access | Times Cited: 42
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 39
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 39
Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance
Hannah N. Bell, Weiping Zou
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 521-550
Closed Access | Times Cited: 20
Hannah N. Bell, Weiping Zou
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 521-550
Closed Access | Times Cited: 20
The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment
Maik Luu, Burkhard Schütz, Matthias Lauth, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1588-1588
Open Access | Times Cited: 26
Maik Luu, Burkhard Schütz, Matthias Lauth, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1588-1588
Open Access | Times Cited: 26
Intratumoral microbiota: implications for cancer onset, progression, and therapy
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 14
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 14
Lab-on-chip technologies for exploring the gut–immune axis in metabolic disease
Alexandra Wheeler, Verena Stoeger, Róisı́n M. Owens
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1266-1292
Open Access | Times Cited: 8
Alexandra Wheeler, Verena Stoeger, Róisı́n M. Owens
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1266-1292
Open Access | Times Cited: 8
Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Cancer Management and Research (2025) Vol. Volume 17, pp. 171-192
Open Access | Times Cited: 1
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Cancer Management and Research (2025) Vol. Volume 17, pp. 171-192
Open Access | Times Cited: 1
The role of short-chain fatty acids in cancer prevention and cancer treatment
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 6
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 6
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Microbiome and cancer: from mechanistic implications in disease progression and treatment to development of novel antitumoral strategies
Marian Constantin, Mariana Carmen Chifiriuc, Grigore Mihăescu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Marian Constantin, Mariana Carmen Chifiriuc, Grigore Mihăescu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access
Streptococcus lutetiensis inhibits CD8+ IL17A+ TRM cells and leads to gastric cancer progression and poor prognosis
Huiyu Wang, Wenhua You, Zining Zhu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Huiyu Wang, Wenhua You, Zining Zhu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Harmony Within: Unravelling the Microbiome–Immune System Symbiosis for Health
Anuupama Suchiita, Neelu Gupta, Kajal Nandi, et al.
Advanced Gut & Microbiome Research (2025) Vol. 2025, Iss. 1
Open Access
Anuupama Suchiita, Neelu Gupta, Kajal Nandi, et al.
Advanced Gut & Microbiome Research (2025) Vol. 2025, Iss. 1
Open Access
Defining a ‘cells to society’ research framework for appendiceal tumours
Andreana N. Holowatyj, Michael J. Overman, Konstantinos I. Votanopoulos, et al.
Nature reviews. Cancer (2025)
Closed Access
Andreana N. Holowatyj, Michael J. Overman, Konstantinos I. Votanopoulos, et al.
Nature reviews. Cancer (2025)
Closed Access
Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development
Menatallah Rayan, Tahseen S Sayed, Ola Hussein, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Menatallah Rayan, Tahseen S Sayed, Ola Hussein, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
The impact of the human gut microbiome on the treatment of autoimmune disease
Renuka R. Nayak, Diego Orellana
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 107-130
Open Access | Times Cited: 4
Renuka R. Nayak, Diego Orellana
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 107-130
Open Access | Times Cited: 4
Gut microbiome and tumor immunotherapy
Mohini Vig, Shweta Dubey
International review of cell and molecular biology (2025)
Closed Access
Mohini Vig, Shweta Dubey
International review of cell and molecular biology (2025)
Closed Access
Turn cold tumors hot by reprogramming the tumor microenvironment
Xiangliang Yuan, Yi Xiao, Dihua Yu
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 466-470
Closed Access
Xiangliang Yuan, Yi Xiao, Dihua Yu
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 466-470
Closed Access
Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response
Karen S. Sfanos
Cancer Research (2023) Vol. 83, Iss. 18, pp. 2985-2986
Closed Access | Times Cited: 9
Karen S. Sfanos
Cancer Research (2023) Vol. 83, Iss. 18, pp. 2985-2986
Closed Access | Times Cited: 9
Microbial regulation of ferroptosis in cancer
Qiming Zhang, Shyamal Goswami, Ömer Yılmaz
Nature Cell Biology (2024) Vol. 26, Iss. 1, pp. 41-42
Open Access | Times Cited: 3
Qiming Zhang, Shyamal Goswami, Ömer Yılmaz
Nature Cell Biology (2024) Vol. 26, Iss. 1, pp. 41-42
Open Access | Times Cited: 3
Tryptophan metabolism and kynurenine metabolites in cancer: systemic nutritional and metabolic implications
Alessio Molfino, Giovanni Imbimbo, Carmen Gallicchio, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2024) Vol. 27, Iss. 3, pp. 316-321
Closed Access | Times Cited: 3
Alessio Molfino, Giovanni Imbimbo, Carmen Gallicchio, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2024) Vol. 27, Iss. 3, pp. 316-321
Closed Access | Times Cited: 3
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody
Pei-Jung Lee, Chien‐Min Hung, Ai‐Jen Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Pei-Jung Lee, Chien‐Min Hung, Ai‐Jen Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3